These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 15845431)
1. Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection. Visnegarwala F; Chen L; Raghavan S; Tedaldi E J Infect; 2005 May; 50(4):331-7. PubMed ID: 15845431 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients. Imazeki F; Yokosuka O; Fukai K; Kanda T; Kojima H; Saisho H Liver Int; 2008 Mar; 28(3):355-62. PubMed ID: 18290778 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia. Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C is associated with type 2 diabetes mellitus in HIV-infected persons without traditional risk factors. Jain MK; Aragaki C; Fischbach L; Gibson S; Arora R; May L; Vardhineni K; Lee WM HIV Med; 2007 Nov; 8(8):491-7. PubMed ID: 17944681 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London. Mohsen AH; Murad S; Easterbrook PJ HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288 [TBL] [Abstract][Full Text] [Related]
6. Specific phenotype associated with diabetes mellitus secondary to chronic hepatitis C infection. Poussier A; Lebouvier M; Penfornis A; Di Martino V; Buffier P; Verges B; Hillon P; Petit JM Diabet Med; 2008 Oct; 25(10):1237-40. PubMed ID: 19046205 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus seropositivity in a South African Cohort of HIV co-infected, ARV naïve patients is associated with renal insufficiency and increased mortality. Parboosing R; Paruk I; Lalloo UG J Med Virol; 2008 Sep; 80(9):1530-6. PubMed ID: 18649335 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: a cross-sectional study. Squillace N; Lapadula G; Torti C; Orlando G; Mandalia S; Nardini G; Beghetto B; Costarelli S; Guaraldi G HIV Med; 2008 Mar; 9(3):151-9. PubMed ID: 18218000 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of type 2 diabetes mellitus in Brazilian liver transplant candidates: negative association with HCV status. Parolin MB; Zaina FE; Araújo MV; Kupka E; Coelho JC Transplant Proc; 2004 Nov; 36(9):2774-5. PubMed ID: 15621146 [TBL] [Abstract][Full Text] [Related]
11. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals. Tornero C; Alberola J; Tamarit A; Navarro D Clin Microbiol Infect; 2006 Jun; 12(6):555-60. PubMed ID: 16700705 [TBL] [Abstract][Full Text] [Related]
12. Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population. Reiche EM; Bonametti AM; Morimoto HK; Morimoto AA; Wiechemann SL; Matsuo T; Vissoci Reiche F; Vogler IH Int J Mol Med; 2008 Mar; 21(3):387-95. PubMed ID: 18288387 [TBL] [Abstract][Full Text] [Related]
13. Association between hepatitis C, diabetes mellitus, and race. a case-control study. Thuluvath PJ; John PR Am J Gastroenterol; 2003 Feb; 98(2):438-41. PubMed ID: 12591065 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus infection, increased serum ferritin and hyperinsulinemia. Garrido Serrano A; Guerrero Igea FJ; Lepe Jiménez JA; Palomo Gil S; Grilo Reina A Rev Esp Enferm Dig; 2001 Oct; 93(10):639-48. PubMed ID: 11767488 [TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Zein CO; Levy C; Basu A; Zein NN Am J Gastroenterol; 2005 Jan; 100(1):48-55. PubMed ID: 15654780 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of new-onset diabetes mellitus in Brazilian liver transplant recipients: association with HCV infection. Parolin MB; Zaina FE; Araújo MV; Kupka E; Coelho JC Transplant Proc; 2004 Nov; 36(9):2776-7. PubMed ID: 15621147 [TBL] [Abstract][Full Text] [Related]
17. Characteristics and survival of HIV-infected patients not screened for hepatitis C virus infection in a hospital-based cohort. Bénet T; D'Oliveira A; Voirin N; Livrozet JM; Cotte L; Peyramond D; Chidiac C; Touraine JL; Fabry J; Trepo C; Allard R; Vanhems P J Viral Hepat; 2007 Oct; 14(10):730-5. PubMed ID: 17875008 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication. Huang JF; Dai CY; Hwang SJ; Ho CK; Hsiao PJ; Hsieh MY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Shin SJ; Chang WY; Chuang WL; Yu ML Am J Gastroenterol; 2007 Jun; 102(6):1237-43. PubMed ID: 17531012 [TBL] [Abstract][Full Text] [Related]
19. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344 [TBL] [Abstract][Full Text] [Related]
20. Incidence of and risk factors for insulin resistance in treatment-naive HIV-infected patients 48 weeks after starting highly active antiretroviral therapy. Palacios R; Merchante N; Macias J; González M; Castillo J; Ruiz J; Márquez M; Gómez-Mateos J; Pineda JA; Santos J Antivir Ther; 2006; 11(4):529-35. PubMed ID: 16856627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]